Real-time enrollment status for this focal segmental glomerulosclerosis clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:07 PM UTC
| NCT Number | NCT07220083 |
| Recruiting Status | Recruiting |
| Condition | Focal Segmental Glomerulosclerosis |
| Phase | PHASE3 |
| Target Enrollment | 286 participants |
| Active Locations | 77 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | October 14, 2026 (1 week ago) |
As of October 21, 2026: Clinical trial NCT07220083 is currently recruiting participants. This phase3 study for focal segmental glomerulosclerosis is actively seeking new participants at 77 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07220083 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 77 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07220083 was last updated 1 week ago (October 14, 2026). HelloStudys verifies this status automatically.